- HK$254.54bn
- HK$243.28bn
- CNY27.21bn
Annual income statement for Beigene, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | PROSPECTUS | ARS | ARS | ARS | ARS |
Standards: | CAS | CAS | CAS | CAS | CAS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 2,120 | 7,589 | 9,566 | 17,423 | 27,214 |
Cost of Revenue | |||||
Gross Profit | 1,634 | 6,528 | 7,663 | 14,713 | 22,951 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 13,367 | 17,168 | 22,992 | 26,234 | 31,376 |
Operating Profit | -11,247 | -9,580 | -13,425 | -8,810 | -4,162 |
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -11,249 | -9,579 | -13,427 | -6,208 | -4,163 |
Provision for Income Taxes | |||||
Net Income After Taxes | -11,407 | -9,748 | -13,642 | -6,716 | -4,978 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | -11,384 | -9,748 | -13,642 | -6,716 | -4,978 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -11,384 | -9,748 | -13,642 | -6,716 | -4,978 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -8.53 | -7.3 | -10.2 | -4.95 | -3.66 |
Dividends per Share |